Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - thidiazuron - suspension concentrate - thidiazuron uron active 500.0 g/l - growth regulator - cotton - defoliation of cotton plants | defoliation aid

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kenso corporation (m) sdn. bhd. - thidiazuron - suspension concentrate - thidiazuron uron active 500.0 g/l - growth regulator - cotton - defoliation of cotton plants | defoliation aid

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

australis crop protection pty ltd - thidiazuron - suspension concentrate - thidiazuron uron active 500.0 g/l - growth regulator - cotton - pre harvest | except crop-seed production - defoliation of cotton plants | defoliation aid

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - thidiazuron; diuron - suspension concentrate - thidiazuron uron active 240.0 g/l; diuron urea-substituted active 120.0 g/l - herbicide - cotton - defoliation of cotton plants | defoliation aid

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

conquest crop protection pty ltd - thidiazuron - suspension concentrate - thidiazuron uron active 500.0 g/l - growth regulator - cotton - pre-harvest - defoliation of cotton plants | defoliation aid

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sabakem pty ltd - thidiazuron - suspension concentrate - thidiazuron uron active 500.0 g/l - growth regulator - cotton - defoliation of cotton plants | defoliation aid

United States - English - NLM (National Library of Medicine)

greer laboratories, inc. - cotton fiber (unii: 70ldw53roo) (cotton fiber - unii:70ldw53roo) - non-standardized allergenic extracts are indicated for: - skin test diagnosis of patients with a clinical history of allergies to one or more of the specific non-standardized allergens. - immunotherapy for the reduction of allergen-induced allergic symptoms confirmed by appropriate positive skin tests or by in vitro testing for allergen-specific ige antibodies. food extracts have not been proven safe or effective in allergen immunotherapy. non-standardized allergenic extracts are contraindicated in patients with: - severe, unstable or uncontrolled asthma - history of any severe systemic or local allergic reaction to an allergen extract 8.1 pregnancy risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. there are no human or animal data to establish the presence or absence of non-standardize

United States - English - NLM (National Library of Medicine)

antigen laboratories, inc. - cotton fiber (unii: 70ldw53roo) (cotton fiber - unii:70ldw53roo) - cotton fiber 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

United States - English - NLM (National Library of Medicine)

nelco laboratories, inc. - cotton (unii: 7s4u9r5259) (cotton - unii:7s4u9r5259) - cotton 0.1 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

United States - English - NLM (National Library of Medicine)

nelco laboratories, inc. - cotton (unii: 7s4u9r5259) (cotton - unii:7s4u9r5259) - cotton 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t